Suchergebnisse - "Rice, Todd W"

PubPharm (450)

101

Vaccine Effectiveness of Primary Series and Booster Doses against Omicron Variant COVID-19-Associated Hospitalization in the United States

enthalten in: medRxiv : the preprint server for health sciences | 2022

von Adams, K. | Rhoads, J. | Surie, D. | +56

UpdateIn: BMJ. 2022 Oct 11;379:e072065. - PMID 36220174

102

Low-risk penicillin allergy delabeling through a direct oral challenge in immunocompromised and/or multiple drug allergy labeled patients in a critical care setting

enthalten in: The journal of allergy and clinical immunology. In practice | 2022

von Koo, G. | Stollings, J. | Lindsell, C. | +8

103

Protocol for balanced versus saline trialists : living systematic review and individual patient data meta-analysis of randomised controlled trials (BEST-Living study)

enthalten in: Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine | 2022

von Zampieri, F. | Cavalcanti, A. | Di Tanna, G. | +9

104

Association between Availability of Extracorporeal Membrane Oxygenation and Mortality in Patients with COVID-19 Eligible for Extracorporeal Membrane Oxygenation : A Natural Experiment

enthalten in: American journal of respiratory and critical care medicine | 2022

von Gannon, W. | Stokes, J. | Francois, S. | +7

CommentIn: Am J Respir Crit Care Med. 2022 Dec 1;206(11):1432-1433. - PMID 35882064

105

Anti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia : A Randomized, Double-Blind, Placebo-controlled Trial

enthalten in: American journal of respiratory and critical care medicine | 2022

von Criner, G. | Lang, F. | Gottlieb, R. | +20

CommentIn: Am J Respir Crit Care Med. 2022 Jun 1;205(11):1258-1260. - PMID 35442181

106

Assessment of Awake Prone Positioning in Hospitalized Adults With COVID-19 : A Nonrandomized Controlled Trial

enthalten in: JAMA internal medicine | 2022

von Qian, E. | Gatto, C. | Amusina, O. | +42

CommentIn: JAMA Intern Med. 2022 Jun 1;182(6):622-623. - PMID 35435933

107

Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021

enthalten in: The Journal of infectious diseases | 2022

von Lewis, N. | Naioti, E. | Self, W. | +155

108

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO) : a randomised controlled trial

enthalten in: The Lancet. Infectious diseases | 2022

von ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study Group | Self, W. | Sandkovsky, U. | +98

CommentIn: Lancet Infect Dis. 2022 May;22(5):567-569. - PMID 34953521

109

Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Tenforde, M. | Patel, M. | Ginde, A. | +56

UpdateOf: medRxiv. 2021 Jul 08;:. - PMID 34268515

110

Simulation Versus Interactive Mobile Learning for Teaching Extracorporeal Membrane Oxygenation to Clinicians : A Randomized Trial

enthalten in: Critical care medicine | 2022

von Gannon, W. | Stokes, J. | Pugh, M. | +8